€79.66
1.02% yesterday
Amsterdam, Sep 15, 05:35 pm CET
ISIN
CH1216478797
Symbol
DSFIR
Index
AEX
Sector
Industry

DSM-Firmenich Stock price

€79.66
-3.20 3.86% 1M
-16.80 17.42% 6M
-18.06 18.48% YTD
-40.74 33.84% 1Y
-38.10 32.35% 3Y
-38.10 32.35% 5Y
-38.10 32.35% 10Y
-38.10 32.35% 20Y
Amsterdam, Closing price Mon, Sep 15 2025
-0.82 1.02%
ISIN
CH1216478797
Symbol
DSFIR
Index
AEX
Sector
Industry

Key metrics

Basic
Market capitalization
€21.2b
Enterprise Value
€23.8b
Net debt
€2.6b
Cash
€2.9b
Shares outstanding
265.3m
Valuation (TTM | estimate)
P/E
- | 19.7
P/S
- | 1.6
EV/Sales
- | 1.8
EV/FCF
31.3
P/B
1.0
Dividends
DPS
€2.50
Yield 1Y | 5Y
3.1% | 1.3%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
266.0% | 19.3%
Increased
0 Years
Financials (TTM | estimate)
Revenue
- | €13.3b
EBITDA
- | €2.5b
EBIT
- | €1.4b
Net Income
- | €1.1b
Free Cash Flow
€762.0m
Growth (TTM | estimate)
Revenue
- | 3.6%
EBITDA
- | 23.8%
EBIT
- | 144.8%
Net Income
- | 329.9%
Free Cash Flow
1.1%
Margin (TTM | estimate)
Gross
-
EBITDA
- | 18.6%
EBIT
-
Net
- | 8.1%
Free Cash Flow
-
Financial Health
Equity Ratio
66.7%
Return on Equity
1.1%
ROCE
-
ROIC
-
Debt/Equity
0.3
More
EPS
-
FCF per Share
€2.9
Short interest
-
Employees
29k
Rev per Employee
€450.0k
Show more

Is DSM-Firmenich a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

DSM-Firmenich Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a DSM-Firmenich forecast:

25x Buy
83%
3x Hold
10%
2x Sell
7%

Analyst Opinions

30 Analysts have issued a DSM-Firmenich forecast:

Buy
83%
Hold
10%
Sell
7%

Financial data from DSM-Firmenich

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
6,510 6,510
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense - -
-
-
1,387 1,387
-
21%
- Depreciation and Amortization 601 601
13% 13%
9%
EBIT (Operating Income) EBIT 786 786
-
12%
Net Profit 510 510
-
8%

In millions EUR.

Don't miss a Thing! We will send you all news about DSM-Firmenich directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

DSM-Firmenich AG is an innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. The firm offers a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet. The company was founded on May 16, 1902 and is headquartered in Kaiseraugst, Switzerland.

Head office Switzerland
CEO Dimitri Vreeze
Employees 28,608
Founded 1902
Website www.dsm-firmenich.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today